
2cureX AB (publ) 2CUREX.ST
2CUREX.ST
2cureX AB (publ) MODTX.ST
Modus Therapeutics Holding AB (publ) AINO.ST
Aino Health AB (publ) EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ) QLIFE.ST
Qlife Holding AB (publ) ACOU.ST
AcouSort AB (publ) EPIS-B.ST
Episurf Medical AB (publ) FLUI.ST
Fluicell AB (publ) APTA.ST
Aptahem AB (publ) ORTI-B.ST
Ortivus AB (publ)
2cureX AB (publ) MODTX.ST
Modus Therapeutics Holding AB (publ) AINO.ST
Aino Health AB (publ) EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ) QLIFE.ST
Qlife Holding AB (publ) ACOU.ST
AcouSort AB (publ) EPIS-B.ST
Episurf Medical AB (publ) FLUI.ST
Fluicell AB (publ) APTA.ST
Aptahem AB (publ) ORTI-B.ST
Ortivus AB (publ)
Performance
Periode | 2CUREX.ST | MODTX.ST | AINO.ST | EXPRS2.ST | QLIFE.ST | ACOU.ST | EPIS-B.ST | FLUI.ST | APTA.ST | ORTI-B.ST |
---|---|---|---|---|---|---|---|---|---|---|
6M | 158.45 % | -64.77 % | 4.52 % | 10.31 % | 5.77 % | -23.99 % | -58.54 % | 15.97 % | -24.38 % | -24.49 % |
YTD | 282.50 % | -74.38 % | -13.33 % | -12.30 % | 5.77 % | -73.48 % | -64.58 % | -37.22 % | -14.93 % | -23.45 % |
1Y | 173.21 % | -69.11 % | 73.33 % | -39.34 % | -9.84 % | -76.76 % | -64.28 % | -45.24 % | -22.47 % | -33.53 % |
3Y | -83.22 % | -77.89 % | -8.71 % | -94.85 % | -99.98 % | -81.53 % | -97.30 % | -98.68 % | -97.51 % | -78.82 % |
5Y | -90.22 % | -91.41 % | -78.63 % | -95.81 % | -99.99 % | -85.53 % | -97.76 % | -99.53 % | -99.29 % | -80.18 % |
10Y | -79.89 % | -91.41 % | -98.27 % | -89.89 % | -99.99 % | -85.53 % | -99.59 % | -99.74 % | -99.84 % | -67.45 % |
From the beginning | -79.89 % | -91.41 % | -98.27 % | -89.89 % | -99.99 % | -85.53 % | -99.28 % | -99.74 % | -99.85 % | -96.90 % |